News

Africa: Statement Against Travel Restrictions Inresponse to Mpox and Marburg Virus Outbreaks

todayOctober 9, 2024 1

Background
share close

[ad_1]

8 October 2024 — In light of the ongoing Mpox and Marburg virus outbreaks, the Africa Centres for Disease Control and Prevention (Africa CDC) urges all countries to refrain from implementing travel bans or movement restrictions targeting African nations. Such measures are inconsistent with international health guidelines and risk undermining public health responses, deepening economic challenges, and reigniting the inequities and mistrust that surfaced during the COVID-19 pandemic, particularly between the Global North and the Global South.

Under the International Health Regulations (2005), travel restrictions are discouraged unless there is compelling evidence to justify them. Historically, these measures have proven counterproductive -delaying response efforts, fostering public anxiety, and disrupting global mobility. The World Health Organization (WHO) and Africa CDC recommend focusing on stronger surveillance, early detection, case management, targeted vaccination, and community engagement as the most effective strategies to manage outbreaks.

Africa CDC commends the leadership of African countries currently managing Mpox and Marburg virus outbreaks for their swift action, transparency, and dedication to public health. These countries are taking decisive action and need support to enhance their surveillance systems, strengthen case management protocols, and expand contact tracing efforts. In collaboration with global and regional partners, Africa CDC has deployed support and expert teams to the most affected areas, ensuring timely access to medical countermeasures (MCMs) such as diagnostics, therapeutics, and vaccines.